Cite

HARVARD Citation

    Linch, S. et al. (2015). Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record